Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-042321

Options or other derivatives

  • Director acquired 124,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kerr Giles Francis Bertram Director 2018-06-22 Grant or award · Option to purchase Ordinary Shares +124,000 124,000 D: show line 1 in the form
Loading xslF345X03/a4.xml…